Influvac clinical trials
How each study uses influvac is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Trivalent influenza subunit vaccine Influvac
- 5
Studies by the year they started
6 studies that test it; most in 2004 (1)
| Year | Studies |
|---|---|
| 2004 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 1
Abbott Biologicals (3) · Abbott (1) · Solvay Biologicals (1) · National Institute of Cardiology, Warsaw, Poland (1)
Studies
Open first, then newest update. How each study uses influvac is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the Southern Hemisphere 2015 SeasonCompletedPhase 3AbbottNCT02381418Written as Trivalent influenza subunit vaccine Influvac
- Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2012/2013 SeasonCompletedPhase 3Abbott BiologicalsNCT01633749Written as Trivalent influenza subunit vaccine Influvac
- Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 09/10 SeasonCompletedPhase 3Abbott BiologicalsNCT00881842Written as Trivalent influenza subunit vaccine Influvac
- Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2010/2011 SeasonCompletedPhase 3Abbott BiologicalsNCT01146015Written as Trivalent influenza subunit vaccine Influvac
- Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 08/09 Season.CompletedPhase 3Solvay BiologicalsNCT00665509Written as Trivalent influenza subunit vaccine Influvac
- Influenza Vaccination in Prevention From Acute Coronary Events in Coronary Artery Disease - FLUCAD StudyCompletedPhase 2/3National Institute of Cardiology, Warsaw, PolandNCT00371098Written as Influenza vaccination: Influvac (SolvayPharma)